Elhai, M. Et Al. 2022. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. The Lancet Rheumatology , vol.4, no.11 .

Elhai, M., Sritharan, N., Boubaya, M., Balbir-Gurman, A., Siegert, E., Hachulla, E., ... de Vries-Bouwstra, J.(2022). Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. The Lancet Rheumatology , vol.4, no.11.

Elhai, Muriel Et Al. "Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort," The Lancet Rheumatology , vol.4, no.11, 2022

Elhai, Muriel Et Al. "Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort." The Lancet Rheumatology , vol.4, no.11, 2022

Elhai, M. Et Al. (2022) . "Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort." The Lancet Rheumatology , vol.4, no.11.

@article{article, author={Muriel Elhai Et Al. }, title={Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort}, journal={The Lancet Rheumatology}, year=2022}